|
Exendin 9-39 Clinical Trials
2 actively recruiting trials across 2 locations
Also known as: no other name for exendin-(9-39)
Rochester, Minnesota1 trial
The Role of Islet GLP-1 in the Pathogenesis of Prediabetes
Mayo Clinic in Rochester
Phase 2
San Antonio, Texas1 trial
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
Texas Diabetes Institute - University Health System
Early 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.